Qiuliang Wu

1.1k total citations
37 papers, 922 citations indexed

About

Qiuliang Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qiuliang Wu has authored 37 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Qiuliang Wu's work include RNA modifications and cancer (8 papers), Viral-associated cancers and disorders (6 papers) and Cancer-related molecular mechanisms research (5 papers). Qiuliang Wu is often cited by papers focused on RNA modifications and cancer (8 papers), Viral-associated cancers and disorders (6 papers) and Cancer-related molecular mechanisms research (5 papers). Qiuliang Wu collaborates with scholars based in China, Hong Kong and United States. Qiuliang Wu's co-authors include Yi‐Xin Zeng, Jian‐Yong Shao, Li–Fu Hu, Ingemar Ernberg, Li Zhang, Yuhong Li, Nian‐Ji Cui, Gang Cheng, Xin‐Yuan Guan and Dan Xie and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Cellular Biochemistry.

In The Last Decade

Qiuliang Wu

37 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiuliang Wu China 16 446 407 275 140 131 37 922
Toshiyuki Horikawa Japan 12 678 1.5× 326 0.8× 240 0.9× 83 0.6× 80 0.6× 13 929
Barbara Loftus Ireland 17 527 1.2× 608 1.5× 244 0.9× 219 1.6× 108 0.8× 30 1.2k
Fedor Denkers Netherlands 17 302 0.7× 523 1.3× 225 0.8× 161 1.1× 353 2.7× 28 1.0k
Hui‐Lan Rao China 20 664 1.5× 259 0.6× 142 0.5× 189 1.4× 55 0.4× 44 1.1k
G. B. Snow Netherlands 12 338 0.8× 286 0.7× 129 0.5× 195 1.4× 302 2.3× 17 788
Charles Schneider United States 17 654 1.5× 260 0.6× 282 1.0× 172 1.2× 258 2.0× 45 993
Sumita Trivedi United States 17 843 1.9× 417 1.0× 170 0.6× 140 1.0× 183 1.4× 33 1.5k
Volkert B. Wreesmann United States 22 424 1.0× 440 1.1× 151 0.5× 413 3.0× 357 2.7× 32 1.4k
Pauline Finlay United Kingdom 12 535 1.2× 503 1.2× 261 0.9× 103 0.7× 48 0.4× 16 1.0k
Christof Hofele Germany 24 539 1.2× 729 1.8× 263 1.0× 396 2.8× 409 3.1× 47 1.6k

Countries citing papers authored by Qiuliang Wu

Since Specialization
Citations

This map shows the geographic impact of Qiuliang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuliang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuliang Wu more than expected).

Fields of papers citing papers by Qiuliang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiuliang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuliang Wu. The network helps show where Qiuliang Wu may publish in the future.

Co-authorship network of co-authors of Qiuliang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiuliang Wu. A scholar is included among the top collaborators of Qiuliang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiuliang Wu. Qiuliang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Jia-Bin, et al.. (2018). RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis. Cell Death and Disease. 9(11). 1085–1085. 14 indexed citations
2.
Feng, Yanfen, Hui‐Lan Rao, Yiyan Lei, et al.. (2017). CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China. Chinese Journal of Cancer. 36(1). 43–43. 28 indexed citations
3.
Yan, Shumei, Fan He, Huini Wu, et al.. (2016). Increased APOBEC3B Predicts Worse Outcomes in Lung Cancer: A Comprehensive Retrospective Study. Journal of Cancer. 7(6). 618–625. 39 indexed citations
4.
Chen, Yan, Zhiguo Hu, Yu Zhang, & Qiuliang Wu. (2016). Gestational intraplacental choriocarcinoma in a term pregnancy and delivery: A case report and review of the literature. 9(3). 6868–6872. 1 indexed citations
5.
Wang, Dong, Yan Lin, Bei Gao, et al.. (2016). Reduced Expression of FADS1 Predicts Worse Prognosis in Non-Small-Cell Lung Cancer. Journal of Cancer. 7(10). 1226–1232. 19 indexed citations
6.
Chen, Kai, et al.. (2013). Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma. Human Pathology. 44(10). 2126–2131. 15 indexed citations
7.
Xu, Tao, et al.. (2012). Primary nasopharyngeal adenocarcinoma: A review. Asia-Pacific Journal of Clinical Oncology. 8(2). 123–131. 12 indexed citations
8.
Zhao, Yuanyuan, Sheng Ye, He Huang, et al.. (2011). Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin’s lymphoma of mucosa-associated lymphoid tissue type. Tumor Biology. 32(5). 913–920. 7 indexed citations
9.
Cai, Muyan, Hui‐Lan Rao, Qiuliang Wu, et al.. (2010). Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma. Cancer Science. 101(6). 1543–1549. 80 indexed citations
10.
Zhou, Shui‐Hong, Shenqing Wang, Qiuliang Wu, Jun Fan, & Qinying Wang. (2008). Expression of Glucose Transporter-1 and -3 in the Head and Neck Carcinoma – The Correlation of the Expression with the Biological Behaviors. ORL. 70(3). 189–194. 48 indexed citations
11.
Zhou, Shui‐Hong, et al.. (2008). Clinical Significance of FDG Single-Photon Emission Computed Tomography: Computed Tomography in the Diagnosis of Head and Neck Cancers and Study of Its Mechanism. Cancer Biotherapy and Radiopharmaceuticals. 23(6). 701–714. 19 indexed citations
12.
Chen, Haihong, et al.. (2008). The effects of angiopoietin-2 on the growth of tongue carcinoma. British Journal of Oral and Maxillofacial Surgery. 47(1). 14–19. 4 indexed citations
13.
Ma, Guowei, Xu Zhang, Junye Wang, et al.. (2006). A study of molecular resection margins for esophageal squamous cell carcinoma using large pathologic sections. Chinese Journal of Clinical Oncology. 3(5). 315–321. 1 indexed citations
14.
Wang, Na, Qiuliang Wu, Yan Fang, et al.. (2005). Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome. Journal of Translational Medicine. 3(1). 26–26. 49 indexed citations
15.
Liu, Weiwei, et al.. (2005). Overexpression of MMP‐2 in laryngeal squamous cell carcinoma: A potential indicator for poor prognosis. Otolaryngology. 132(3). 395–400. 51 indexed citations
16.
Shao, Jian‐Yong, Yuhong Li, Qiuliang Wu, et al.. (2004). Comparison of plasma Epstein–Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer. 100(6). 1162–1170. 172 indexed citations
17.
Xie, Dan, Sze Hang Lau, Jonathan S. T. Sham, et al.. (2004). Up‐regulated expression of cytoplasmic clusterin in human ovarian carcinoma. Cancer. 103(2). 277–283. 76 indexed citations
18.
Yun, Jing‐Ping, et al.. (2003). Nucleophosmin/B23 is a proliferate shuttle protein associated with nuclear matrix. Journal of Cellular Biochemistry. 90(6). 1140–1148. 60 indexed citations
19.
Wu, Qiuliang. (2000). Relationship Between the Expression of CD44V6 and Invasion or Metastasis in NPC. 1 indexed citations
20.
Huang, Di, Bi‐Jun Huang, & Qiuliang Wu. (1999). The examination of an EBV-DNase gene fragment in the paraffin-embedded NPC, precancerous and from high-risk population nasopharyngeal tissues. Chinese Journal of Cancer Research. 11(2). 85–87. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiyuki Horikawa Breakdown of academic impact, for papers by Barbara Loftus Breakdown of academic impact, for papers by Fedor Denkers Breakdown of academic impact, for papers by Hui‐Lan Rao Breakdown of academic impact, for papers by G. B. Snow Breakdown of academic impact, for papers by Charles Schneider Breakdown of academic impact, for papers by Sumita Trivedi Breakdown of academic impact, for papers by Volkert B. Wreesmann Breakdown of academic impact, for papers by Pauline Finlay Breakdown of academic impact, for papers by Christof Hofele
Rankless by CCL
2026